CINECA IRIS Institutional Research Information System

MARINI, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.405
EU - Europa 2.475
AS - Asia 1.575
OC - Oceania 36
AF - Africa 32
SA - Sud America 26
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.552
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.284
CN - Cina 745
IT - Italia 690
IE - Irlanda 351
SG - Singapore 292
DE - Germania 248
SE - Svezia 240
FR - Francia 145
AT - Austria 138
GB - Regno Unito 131
IN - India 130
UA - Ucraina 122
FI - Finlandia 110
CA - Canada 97
KR - Corea 80
PL - Polonia 80
VN - Vietnam 66
ID - Indonesia 58
JP - Giappone 57
BE - Belgio 37
ES - Italia 34
IR - Iran 33
AU - Australia 31
HK - Hong Kong 29
CH - Svizzera 26
NL - Olanda 22
MX - Messico 21
DK - Danimarca 20
TW - Taiwan 20
RU - Federazione Russa 15
TH - Thailandia 15
TR - Turchia 15
BR - Brasile 14
AL - Albania 13
PT - Portogallo 13
GR - Grecia 11
IL - Israele 10
SN - Senegal 10
LT - Lituania 7
NG - Nigeria 7
EG - Egitto 6
IS - Islanda 6
CO - Colombia 5
NZ - Nuova Zelanda 5
UZ - Uzbekistan 5
CL - Cile 4
GA - Gabon 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
EU - Europa 3
MY - Malesia 3
RS - Serbia 3
CY - Cipro 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
IQ - Iraq 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AM - Armenia 1
AR - Argentina 1
BG - Bulgaria 1
CM - Camerun 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
JO - Giordania 1
KE - Kenya 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
PA - Panama 1
PK - Pakistan 1
PR - Porto Rico 1
RO - Romania 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
UG - Uganda 1
Totale 8.552
Salva come PNG Salva come JPEG
Città #
Chandler 583
Dublin 345
Santa Clara 300
Fairfield 276
Ann Arbor 269
Beijing 239
Singapore 238
Ashburn 201
Houston 192
Woodbridge 152
Torino 149
Vienna 134
Nyköping 122
Wilmington 117
Seattle 112
Turin 109
Jacksonville 96
Dearborn 94
Medford 80
Pisa 80
Columbus 77
Villeurbanne 76
Redwood City 74
Cambridge 70
Princeton 70
Warsaw 65
Boardman 58
Jakarta 56
Fremont 55
Guangzhou 53
Ottawa 46
Dong Ket 40
Shanghai 40
Brussels 32
Nanjing 31
Milan 30
Toronto 30
San Diego 28
Munich 27
Helsinki 25
New York 24
Hangzhou 23
Washington 23
Boston 22
Mumbai 20
Los Angeles 19
Tokyo 19
Rome 17
Frankfurt am Main 14
Zhengzhou 14
Brisbane 13
Pune 13
Taipei 13
Tübingen 13
Bangkok 12
Chengdu 12
Jinan 12
London 12
Norwalk 12
Nuremberg 12
Copenhagen 11
Phoenix 11
Pittsburgh 11
Amsterdam 10
Baltimore 10
Glendale 10
Hong Kong 10
Hyderabad 10
Seoul 10
Bengaluru 9
Hefei 9
Paris 9
Changchun 8
Chongqing 8
Duncan 8
Fuzhou 8
Hanoi 8
Delhi 7
Hamburg 7
Kunming 7
Leinì 7
Madrid 7
Mestre 7
Naples 7
New Delhi 7
Piemonte 7
Shenyang 7
Toledo 7
Wuhan 7
Belfast 6
Busan 6
Hebei 6
Lachine 6
Mountain View 6
Nanchang 6
Philadelphia 6
Portiragnes 6
Shiraz 6
Tappahannock 6
Verona 6
Totale 5.500
Salva come PNG Salva come JPEG
Nome #
Electrophilic Warhead-Based Design of Compounds Preventing NLRP3 Inflammasome-Dependent Pyroptosis 628
Development of covalent NLRP3 inflammasome inhibitors: chemistry and biological activity 314
In the search for new NLRP3 inhibitors: chemical modulation of the 1-(piperidin-4-yl)-1,3-dihydro-2 Hbenzo[d]imidazole-2-one scaffold 306
NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease 266
Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile 219
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins 199
Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: Application of a bioisosteric scaffold hopping approach to flufenamic acid 197
Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approach 187
New nitric oxide or hydrogen sulfide releasing aspirins 177
Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies 175
α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis 170
A Nonmetal-Containing Nitric Oxide Donor Activated with Single-Photon Green Light 167
Design, synthesis, and biological evaluation of flufenamic acid derived bioisosteres as inhibitors of aldo-keto reductase 1C3 (AKR1C3) expressed in prostate cancer 166
Synthesis and preliminary biological profile of new NO-donor tolbutamide analogues. 158
Glargine insulin loaded lipid nanoparticles: Oral delivery of liquid and solid oral dosage forms 155
NEW HYDROXYAZOLES INHIBITORS OF ALDO-KETO REDUCTASE 1C3 (AKR1C3) OBTAINED BY SCAFFOLD HOPPING FROM FLUFENAMIC ACID AND INDOMETHACIN FOR CASTRATE RESISTANT PROSTATE CANCER 153
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 150
gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension 145
Design, Synthesis, and Evaluation of Acrylamide Derivatives as Direct NLRP3 Inflammasome Inhibitors 144
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties 138
A new class of NO-donor H3-Antagonists 135
Structural and biological characterization of new hybrid drugs joining an HDAC inhibitor to different NO-donors 135
Searching for new NO-donor aspirin-like molecules: furoxanylacyl derivatives of salicylic acid and related furazans 135
Amphiphilic NO-Donor Antioxidants 134
Water-Soluble Nitric-Oxide-Releasing Acetylsalicylic Acid (ASA) Prodrugs 132
Searching for new NO-donor Aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid 131
NO-Donor Melatonin Derivatives: Synthesis And In Vitro Pharmacological Characterization 128
Novel Antioxidant Agents Deriving From Molecular Combination of Vitamin C and NO-donor moieties 124
Allanblackia floribunda Oliv.: an aphrodisiac plant with vasorelaxant properties 123
Design, Synthesis and Pharmacological Evaluation of Anti-Pyroptotic Compounds Acting on NLRP3 Inflammasome Signaling Pathway: a New Start for Anti-Inflammatory Drugs? 123
Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3 121
Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease 119
Aceclofenac-galactose conjugate: design, synthesis, characterization and pharmacological and toxicological evaluations 114
Non-conventional extractions and antioxidant properties evaluation of microalga Spirulina maxima 113
New organic nitrate-containing benzyloxy isonipecotanilide derivatives with vasodilatory and anti-platelet activity 112
Methotrexate-Loaded Solid Lipid Nanoparticles: Protein Functionalization to Improve Brain Biodistribution 108
Targeting Castration Resistant Prostate Cancer (CRPC) by innovative AKR1C3 inhibitors based on the 3-hydroxybenzoisoxazole structure 107
Chemical modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2h-benzo[d]imidazole-2-one scaffold as a novel NLRP3 inhibitor 105
Nitrooxyacyl Derivatives of Salicylic Acid: Aspirin-Like Molecules that Covalently Inactivate Cyclooxygenase-1 103
An evaluation of the antioxidant properties of Arthrospira maxima extracts obtained using non-conventional techniques 102
Pharmacological characterization of new NLRP3 inflammasome inhibitors. 93
NEW HYDROXYAZOLES INHIBITORS OF AKR1C3 OBTAINED FROM NSAIDS BY SCAFFOLD HOPPING APPROACH AGAINST CASTRATE RESISTANT PROSTATE CANCER 89
Amphiphile NO-donor antioxidants as polivalent drugs 84
NO-Donor Cyanines As Potential Anti-Alzheimer Drugs 80
Inhibition of NLRP3 ATPase activity: a new strategy to fight chronic inflammatory diseases 77
No-donor phenols: a study of their antioxidant activity 76
NO-Donor Dihydroartemisinin Derivatives as Multitarget Agents for the Treatment of Cerebral Malaria 75
GIFC-2018 - BOOK OF ABSTRACTS 75
Covalent NLRP3 inhibitors: design strategies, synthesis and pharmacological characterization 72
NO-DONOR 1,4-DIHYDROPYRIDINE ANALOGUES OF AMLODIPINE 71
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 70
Targeting NLRP3 inflammasome: development of new covalent and non-covalent inhibitors of ATPase activity 70
NEW NON-COVALENT INHIBITORS OF NLRP3 INFLAMMASOME ATPASE ACTIVITY 69
Intranasal lipid nanocarriers: Uptake studies with fluorescently labeled formulations 67
Synthesis and Pharmacological Evaluation of Novel H3 Antagonists Endowed with NO-Donor Properties 65
New class of NO-donor soluble aspirins 61
Structure-Antioxidant Activity Relationships in a Series of NO-Donor Phenols 61
Nitrooxymethyl substituted analogues of Celecoxib and Rofecoxib 59
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein 58
Vasodilating profile of a new series of analogues of GTN 54
Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation 52
New tools for the development of direct NLRP3 inflammasome inhibitors 52
Macromolecules in Drug Delivery 51
Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage 49
New Uroselective NO-Donor a1-antagonists 48
Tolerance profile of new organic nitrates with antioxidant properties 48
Tuning NO release of organelle-targeted furoxan derivatives and their cytotoxicity against lung cancer cells 45
L'esame di stato per Farmacisti - Manuale di preparazione 42
Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) – Proceedings from the SOGLI consortium meeting in rome November 2022 36
Design and synthesis of INF195, a new NLRP3 Inflammasome Inhibitor with ex vivo cardioprotective effect 34
Multitarget antioxidant NO-donor organic nitrates: a novel ap-proach to overcome nitrates tolerance, an ex vivo study 34
Galactosylated Prodrugs: A Strategy to Improve the Profile of Nonsteroidal Anti-Inflammatory Drugs 28
NLRP3 INFLAMMASOME-inhibiting compounds and the use thereof 24
Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma 24
Green Solid Lipid Nanoparticles by Fatty Acid Coacervation: An Innovative Nasal Delivery Tool for Drugs Targeting Cerebrovascular and Neurological Diseases 22
Galactose: A Versatile Vector Unveiling the Potentials in Drug Delivery, Diagnostics, and Theranostics 21
New lipophilic organic nitrates: Candidates for chronic skin disease therapy 21
Inflammasome Biology Fundamentals, Role in Disease States, and Therapeutic Opportunities 20
Modulation of the aspartic acid scaffold to identify a new septin-4 covalent binder with anti-metastatic activity in a mouse model of melanoma 19
L'esame di stato per Farmacisti - Tracce svolte e prove pratiche 18
Multitarget antioxidant NO-donor organic nitrates: a novel approach to overcome nitrates tolerance 15
Cell Membrane Fragment-Wrapped Parenteral Nanoemulsions: A New Drug Delivery Tool to Target Gliomas 15
Overcome nitrate tolerance: new perspectives with multitarget antioxidant NO-donor nitrates 15
Concanavalin a Grafted Nanoemulsions for Nasal Delivery: Preliminary Studies with Fluorescently Labelled Formulations 12
Ultrasmall solid lipid nanoparticles as a potential innovative delivery system for a drug combination against glioma 1
Totale 8.790
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.572
article - articoli 0
book - libri 0
conference - conferenze 6.808
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.380
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020712 0 0 0 0 0 165 124 92 117 88 61 65
2020/2021895 87 60 59 66 116 62 58 48 111 72 53 103
2021/20221.071 61 60 69 91 51 28 63 57 48 77 253 213
2022/20231.793 143 240 70 200 148 379 211 87 135 44 74 62
2023/2024973 107 134 75 60 69 132 34 78 12 54 68 150
2024/20251.132 46 128 139 205 440 174 0 0 0 0 0 0
Totale 8.790